Live feed16:05:00·1612dPRReleasevia Quantisnow89bio Reports Positive Topline Results from an Expansion Cohort of the Phase 1b/2a Trial of Pegozafermin (BIO89-100) for the Treatment of NASHByQuantisnow·Wall Street's wire, on your screen.ETNB· 89bio Inc.Health Care
